Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab

By Pieringer Herwig   Stuby Ulrike   Pohanka Erich   Biesenbach Georg  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 723-727

Springer Publishing Company

Access to resources Recommend Favorite

A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept

By Akgül Özgür   Kılıç Gamze   Kılıç Erkan   Cüce İsa   Özgöçmen Salih  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 443-444

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Concomitant Immunomodulator Use on Long-Term Outcomes in Patients Receiving Scheduled Maintenance Infliximab

By Moss Alan   Kim Kyung   Fernandez-Becker Nielsen   Cury Didia   Cheifetz Adam  

Digestive Diseases and Sciences, Vol. 55, Iss. 5, 2010-05 ,pp. : 1413-1420

Springer Publishing Company

Access to resources Recommend Favorite

Psoriasis, erythema nodosum, and nummular eczema onset in an ankylosing spondylitis patient treated with infliximab

By Sedie A. Delle   Bazzichi L.   Bombardieri S.   Riente L.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 403-404

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement

By Rejón E   Giménez MD   Mayordomo L   Rodríguez S   González MP   Marenco JL  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 5, 2004-10 ,pp. : 323-326

Informa Healthcare

Access to resources Recommend Favorite